Interpretation of the essential updates in guidelines for the prevention and treatment of chronic hepatitis B (Version 2022) / 中华肝脏病杂志
Chinese Journal of Hepatology
; (12): 385-388, 2023.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-986142
Responsible library:
WPRO
ABSTRACT
Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association update the guidelines for the prevention and treatment of chronic hepatitis B (version 2022) in 2022. The latest guidelines recommend more extensive screening and more active antiviral treating for hepatitis B virus infection. This article interprets the essential updates in the guidelines to help deepen understanding and better guide the clinical practice.
Full text:
Available
Health context:
Sustainable Health Agenda for the Americas
/
SDG3 - Health and Well-Being
Health problem:
Goal 9: Noncommunicable diseases and mental health
/
Goal 10: Communicable diseases
/
Target 3.3: End transmission of communicable diseases
/
Target 3.4: Reduce premature mortality due to noncommunicable diseases
Database:
WPRIM (Western Pacific)
Main subject:
Antiviral Agents
/
Hepatitis B virus
/
Hepatitis B, Chronic
/
Gastroenterology
/
Hepatitis B
Limits:
Humans
Language:
Chinese
Journal:
Chinese Journal of Hepatology
Year:
2023
Document type:
Article
